Vera Therapeutics Inc. (VERA)
NASDAQ: VERA
· Real-Time Price · USD
30.62
0.12 (0.39%)
At close: Oct 09, 2025, 10:56 AM
0.39% (1D)
| Bid | 30.58 |
| Market Cap | 1.95B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -218.28M |
| EPS (ttm) | -3.59 |
| PE Ratio (ttm) | -8.53 |
| Forward PE | -6.58 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 30.64 |
| Volume | 212,994 |
| Avg. Volume (20D) | 1,497,398 |
| Open | 30.50 |
| Previous Close | 30.50 |
| Day's Range | 30.20 - 31.00 |
| 52-Week Range | 18.53 - 51.61 |
| Beta | 1.23 |
| Ex-Dividend Date | n/a |
About VERA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VERA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for VERA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
+67.49%
Vera Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
8 months ago
-6.08%
Vera Therapeutics shares are trading lower. The company announced an exclusive license agreement with Stanford University for VT-109.
